Dr. Glenn Davin Haraway, DO

Dr. Haraway practices at Tulsa Vein Institute in Tulsa, Oklahoma.

Dr. Haraway's NPI, 1679679062, was assigned on September 15, 2006. Dr. Haraway graduated from Oklahoma State University College Of Osteopathic Medicine in 1994. Dr. Haraway holds Oklahoma license 3263.

Dr. Haraway's primary practice is Tulsa Vein Institute, at 6901 S Yorktown E Ave, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 706-2161.

Dr. Haraway's primary practice is Tulsa Vein Institute in Tulsa, Oklahoma. Dr. Haraway is also affiliated with Saint Francis Hospital. Dmand AI also links Dr. Haraway to 2 more hospices and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haraway practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Haraway's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Haraway is board certified in hospice and palliative medicine (caq) by the AOA Board of Internal Medicine. Dr. Haraway is licensed in Oklahoma.

Dmand AI lists anxiety, arthritis, atrial fibrillation and flutter, chronic diabetes, chronic embolism thrombosis, chronic hypertension, chronic skin ulcer and cirrhosis of the liver among the conditions Dr. Haraway treats.

CMS data shows 1,035 Medicare services from Dr. Haraway across 14 procedure codes in 2024, for 217 Medicare patients. Medicare paid $129,674 for them. Every service was in an office.

CMS counts 217 Medicare patients who saw Dr. Haraway in 2024. The largest group is 65 to 74, with 116 patients. 71% of them have high blood pressure, and 63% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Haraway's median patient age at 70, with 66% women.

In 2024, Dr. Haraway wrote 289 Medicare Part D claims for 92 patients. 86% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $832 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 6 out of 100 for Dr. Haraway for performance year 2024, reported individually. Dr. Haraway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 285 procedures of varicose vein removal by Dr. Haraway, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Haraway. Dr. Haraway's most frequent co-author is Eliot Nathan Mostow, MD.

CMS Open Payments shows 158 general payments to Dr. Haraway from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Medtronic Vascular, Inc. paid the most, $3,793.

Dr. Haraway graduated from Oklahoma State University College Of Osteopathic Medicine in 1994. Dr. Haraway is a member of AOA.

Dr. Haraway is in network with 15 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.